This article is more than 5 years old. Information may no longer be current.

VIDEO: Clinical trials show similarities between ranibizumab, aflibercept in treating DME

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions and subtitles off, selected

Audio Track

Picture-in-PictureFullscreen

SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Marco A. Zarbin, MD, PhD, discusses a review of randomized clinical trials of anti-VEGF agents for treating diabetic macular edema, including RISE, RIDE, VIVID, VISTA, RESTORE, Protocol T and Protocol S. The review found that both aflibercept and ranibizumab were "equally effective" in inducing a two-step regression in diabetic retinopathy, durability of the anti-VEGFs was "almost identical," and incidence of systemic side effects "was comparable" in all the studies, Zarbin said.

Read more from Association for Research in Vision and Ophthalmology

View all

July 11, 2024

2 min watch

Save

VIDEO: Study focuses on GA lesion growth with monthly pegcetacoplan, avacincaptad pegol

July 08, 2024

1 min read

Save

VR headset for pupillometry may allow screening for relative afferent pupillary defects

July 01, 2024

1 min watch

Save

VIDEO: Individuals with AMD indicate interest in bionic vision options

June 21, 2024

1 min read

Save

Visual acuity worse in patients with dry AMD who smoke

June 20, 2024

1 min read

Save

Health equity data lacking in systematic reviews, meta-analyses in GA space

June 19, 2024

1 min read

Save

Quality of life may decline faster after development of geographic atrophy subtypes

June 16, 2024

5 min watch

Save

VIDEO: Topcon Healthcare launches with focus on AI-driven ‘health care from the eye’

June 12, 2024

1 min watch

Save

VIDEO: Better understanding of Bruch’s membrane may help development of AMD treatments

June 10, 2024

2 min watch

Save

VIDEO: Anti-VEGF biosimilars may offer cost savings, accessibility for AMD treatment

Previous

Next

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment